Bottom line
What is JDSRX's expense ratio?
JDSRX's expense ratio is 1.34%, or about $134 a year on every $10,000 invested. That is more expensive than 79% of small-cap funds we track (median 0.99%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Oct 28, 2026
JDSRX fee table
| Net expense ratio | 1.34% |
|---|---|
| Gross expense ratio | 1.34% |
| Management fee | 0.54% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.3% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What JDSRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| JDSRX | $136 | $425 | $734 | $1,613 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.34% expense ratio costs roughly $72,000 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).